Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
about
Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileutonA unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.eIF5A interacts functionally with eEF2.Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy.New insights into novel inhibitors against deoxyhypusine hydroxylase from plasmodium falciparum: compounds with an iron chelating potential.A rapid and robust assay for the determination of the amino acid hypusine as a possible biomarker for a high-throughput screening of antimalarials and for the diagnosis and therapy of different diseases.
P2860
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
@en
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
@nl
type
label
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
@en
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
@nl
prefLabel
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
@en
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target.
@nl
P921
P1433
P1476
Assessment of deoxyhypusine hydroxylase as a putative, novel drug target
@en
P2093
P2888
P304
P356
10.1007/S00726-009-0406-9
P577
2009-12-03T00:00:00Z